Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.245 SGD | +2.08% | +4.26% | -3.92% |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The opinion of analysts covering the stock has improved over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-3.92% | 170M | C+ | ||
-14.25% | 85.35B | B- | ||
+14.46% | 81.95B | C+ | ||
+9.37% | 28.99B | C+ | ||
-11.40% | 16.98B | B | ||
-0.36% | 16.85B | A- | ||
+0.22% | 15.35B | A- | ||
+4.32% | 12.42B | A- | ||
-2.34% | 11.88B | A- | ||
+32.69% | 12.19B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- QC7 Stock
- Ratings Q & M Dental Group (Singapore) Limited